146 related articles for article (PubMed ID: 36944541)
1. [Chinese expert consensus of albumin-bound paclitaxel in the treatment of breast cancer].
;
Zhonghua Zhong Liu Za Zhi; 2023 Mar; 45(3):203-211. PubMed ID: 36944541
[TBL] [Abstract][Full Text] [Related]
2. Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer.
Tanaka S; Iwamoto M; Kimura K; Matsunami N; Morishima H; Yoshidome K; Nomura T; Morimoto T; Yamamoto D; Tsubota Y; Kobayashi T; Uchiyama K
Clin Breast Cancer; 2015 Jun; 15(3):191-6. PubMed ID: 25579459
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant triweekly nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for Stage II/III HER2-negative breast cancer: evaluation of efficacy and safety.
Shimada H; Ueda S; Saeki T; Shigekawa T; Takeuchi H; Hirokawa E; Sugitani I; Sugiyama M; Takahashi T; Matsuura K; Yamane T; Kuji I; Hasebe T; Osaki A
Jpn J Clin Oncol; 2015 Jul; 45(7):642-9. PubMed ID: 25989989
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticle albumin-bound paclitaxel is superior to liposomal paclitaxel in the neoadjuvant treatment of breast cancer.
Zhang W; Xu Y; Shi X; Huang X; Chen R; Xu H; Shi W; Wan X; Wang Y; He J; Li C; Wang J; Zha X
Nanomedicine (Lond); 2022 Apr; 17(10):683-694. PubMed ID: 35393861
[TBL] [Abstract][Full Text] [Related]
5. A phase II neoadjuvant trial of sequential nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide in locally advanced breast cancer.
Robidoux A; Buzdar AU; Quinaux E; Jacobs S; Rastogi P; Fourchotte V; Younan RJ; Pajon ER; Shalaby IA; Desai AM; Fehrenbacher L; Geyer CE; Mamounas EP; Wolmark N
Clin Breast Cancer; 2010 Feb; 10(1):81-6. PubMed ID: 20133263
[TBL] [Abstract][Full Text] [Related]
6. A phase II trial of dose-dense neoadjuvant gemcitabine, epirubicin, and albumin-bound paclitaxel with pegfilgrastim in the treatment of patients with locally advanced breast cancer.
Yardley DA; Zubkus J; Daniel B; Inhorn R; Lane CM; Vazquez ER; Naot Y; Burris HA; Hainsworth JD
Clin Breast Cancer; 2010 Oct; 10(5):367-72. PubMed ID: 20670921
[TBL] [Abstract][Full Text] [Related]
7. Comparing Neoadjuvant Nab-paclitaxel vs Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer-The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial: A Randomized Phase 3 Clinical Trial.
Gianni L; Mansutti M; Anton A; Calvo L; Bisagni G; Bermejo B; Semiglazov V; Thill M; Chacon JI; Chan A; Morales S; Alvarez I; Plazaola A; Zambetti M; Redfern AD; Dittrich C; Dent RA; Magazzù D; De Fato R; Valagussa P; Tusquets I
JAMA Oncol; 2018 Mar; 4(3):302-308. PubMed ID: 29327055
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy and Safety of Neoadjuvant Chemotherapy Containing Nanoparticle Albumin-Bound Paclitaxel (NabPTX) in Operable Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer].
Yoshioka S; Ota C; Moriguchi Y
Gan To Kagaku Ryoho; 2016 May; 43(5):579-82. PubMed ID: 27210086
[TBL] [Abstract][Full Text] [Related]
9. [Multi-center real world study of the efficacy and safety of albumin-bound paclitaxel in the treatment of advanced breast cancer].
Sang D; Zhou H; Zong H; Yang H; Lu QR; Fan SM; Wang YC; Song LH; Yuan P
Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1114-1121. PubMed ID: 34695904
[No Abstract] [Full Text] [Related]
10. Remarkable response with pembrolizumab plus albumin-bound paclitaxel in 2 cases of HER2-positive metastatic breast cancer who have failed to multi-anti-HER2 targeted therapy.
Li B; Tao W; Shao-Hua Z; Ze-Rui Q; Fu-Quan J; Fan L; Ze-Fei J
Cancer Biol Ther; 2018 Apr; 19(4):292-295. PubMed ID: 29333945
[TBL] [Abstract][Full Text] [Related]
11. Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer.
Wang H; Fan L; Wu X; Han Y
BMC Womens Health; 2022 Jun; 22(1):224. PubMed ID: 35690772
[TBL] [Abstract][Full Text] [Related]
12. Retrospective comparisons of nanoparticle albumin-bound paclitaxel and docetaxel neoadjuvant regimens for breast cancer.
Li Y; Chen X; Zhu Q; Chen R; Xu L; Li S; Shi X; Xu H; Xu Y; Zhang W; Huang X; Zha X; Wang J
Nanomedicine (Lond); 2021 Feb; 16(5):391-400. PubMed ID: 33502252
[No Abstract] [Full Text] [Related]
13. Efficacy of two-weekly nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy for breast cancer.
Xie F; Chen R; Zhang L; Yin Z; Zhu Q; You S; Jiang C; Li Y; Li S; Zha X; Wang J
Nanomedicine (Lond); 2019 Jun; 14(12):1595-1603. PubMed ID: 30977429
[No Abstract] [Full Text] [Related]
14. Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study).
Futamura M; Oba M; Masuda N; Bando H; Okada M; Yamamoto Y; Kin T; Saeki T; Nagashima T; Kuwayama T; Toh U; Hirano A; Inokuchi M; Yamagami K; Mizuno Y; Kojima Y; Nakayama T; Yasojima H; Ohno S
Breast Cancer; 2021 Sep; 28(5):1023-1037. PubMed ID: 33811599
[TBL] [Abstract][Full Text] [Related]
15. Role of Xihuang capsule combined with albumin-bound paclitaxel on the treatment of stage III breast cancer and T cell subsets, survival rate and adverse reactions.
Zhang X; Li H; Wu F; Sun D; Zhang H; Jin L; Kang X; Wang Z
Pak J Pharm Sci; 2023 Mar; 36(2(Special)):619-623. PubMed ID: 37548199
[TBL] [Abstract][Full Text] [Related]
16. Feasibility Study of Weekly Nanoparticle Albumin-Bound Paclitaxel (150 mg/m
Kojima Y; Kawamoto H; Nishikawa T; Hayami R; Shimo A; Haku E; Akiyama K; Tsugawa K
Clin Breast Cancer; 2018 Oct; 18(5):374-379. PubMed ID: 29452759
[TBL] [Abstract][Full Text] [Related]
17. Dose-dense doxorubicin and cyclophosphamide followed by dose-dense albumin-bound paclitaxel plus bevacizumab is safe as adjuvant therapy in patients with early stage breast cancer.
Pippen J; Paul D; Vukelja S; Clawson A; Iglesias J
Breast Cancer Res Treat; 2011 Dec; 130(3):825-31. PubMed ID: 21976055
[TBL] [Abstract][Full Text] [Related]
18. Albumin-bound paclitaxel: the benefit of this new formulation in the treatment of various cancers.
Montana M; Ducros C; Verhaeghe P; Terme T; Vanelle P; Rathelot P
J Chemother; 2011 Apr; 23(2):59-66. PubMed ID: 21571619
[TBL] [Abstract][Full Text] [Related]
19. [Guidelines for clinical application of platinum drugs in breast cancer (2023 edition)].
Breast Cancer Group, Branch of Oncologist, Chinese Medical Doctor Association
Zhonghua Zhong Liu Za Zhi; 2023 Dec; 45(12):1018-1031. PubMed ID: 38110310
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy in HER2-negative breast cancer.
Yang M; Qu H; Liu A; Liu J; Sun P; Li H
J Cancer Res Ther; 2019; 15(7):1561-1566. PubMed ID: 31939438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
